Previous Article | Next Article ![]()
Clinical and Diagnostic Laboratory Immunology, 09 1997, 587-591, Vol 4, No. 5
B Rasoamanana, F Leroy, P Boisier, M Rasolomaharo, P Buchy, E Carniel and S Chanteau
Bacteriological isolation of Yersinia pestis is the reference test for
confirming plague infection, but recovery of the pathogen from human
samples is usually very poor. When the etiology of the disease cannot be
bacteriologically confirmed, it may be useful to possess alternative tests
such as detection of specific circulating antibodies to help guide the
diagnosis. In the present study, the immunoglobulin G (IgG) anti-F1
enzyme-linked immunosorbent assay (ELISA) has been applied to various human
sera to evaluate its large-scale applicability in the high-endemicity
plague foci of Madagascar. The sensitivity of the test was found to be
91.4%, and its specificity was 98.5%. The positive and negative predictive
values were 96 and 96.6%, respectively. Seroconversion was observed on day
7 after onset of the disease. Patients with a positive ELISA result could
be separated into high (82%) and low (18%) IgG anti-F1 responders.
Cross-reactions with eight other infectious diseases prevalent in
Madagascar were scarce and were found in 1 of 27 Mycobacterium
tuberculosis-, 3 of 34 Schistosoma haematobium-, and 1 of 41
Salmonella-infected patients. Finally, the efficiency of the IgG anti-F1
ELISA was evaluated during the Mahajanga, Madagascar, plague outbreak of
1995. When the number of ELISA-positive patients was added to the number of
bacteriologically confirmed and probable cases, the number of positive
patients was increased by 35%. In conclusion, although it does not replace
bacteriology, IgG anti-F1 ELISA is a useful and powerful tool for
retrospective diagnosis and epidemiological surveillance of plague
outbreaks.
Copyright © 1997 by the American Society for Microbiology. All rights reserved.
Field evaluation of an immunoglobulin G anti-F1 enzyme-linked immunosorbent assay for serodiagnosis of human plague in Madagascar
Institut Pasteur, Antananarivo, Madagascar.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. | Infect. Immun. |
|---|---|---|
| J. Clin. Microbiol. | J. Virol. | ALL ASM JOURNALS |